#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Spina bifida Fatty acid oxidation disorder Primary mediastinal large B-cell lymphoma Haematological malignancy Spinal cord injury cervical Ureteric cancer Neuroblastoma Oesophageal carcinoma Transferrin decreased B-cell lymphoma refractory Chondrosarcoma metastatic Leukaemia Paraganglion neoplasm Bulbospinal muscular atrophy congenital Malignant glioma More trials…

    Learn about Rare Diseases

    Hepatic angiosarcoma – Basic Information Idiopathic inflammatory myopathy – Trials in Disease Noonan syndrome – Diagnostics Testicular leiomyosarcoma Paroxysmal nocturnal haemoglobinuria – Diagnostics Arterial tortuosity syndrome Hereditary hypophosphataemic rickets – Life with Disease Osteosarcoma – Trials in Disease Crigler-Najjar syndrome – Basic Information Hepatoblastoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Loperamide PIPOTIAZINE Cetrimide Topiramate Eliglustat Tartrate Crgd-Zw800-1 Iodine (123I) Iobenguane AZD5148 Calcium Folinate Trehalose Dihydrate (Ph.eur.) ZILUCOPLAN Ripretinib Radium Ra 223 Dichloride Satoreotide Tetraxetan Chloride Ion ADX-324 Immunglobulin Somatropin Midazolam Berzosertib More therapies…

    Learn about Your Condition

    Ventricular fibrillation Pruritus Tourette's disorder Gallbladder cancer Death neonatal Endotracheal intubation HER2 positive breast cancer Bone marrow failure Meniscus injury Implantation complication Mitral valve disease Pharyngeal cancer stage I Malignant melanoma stage IV Procedural anxiety Congenital ureteric anomaly More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Virus Diseases

  • Study on the Effectiveness of Interferon Alfa, Interleukin-1, and Interleukin-2 in Treating Non-Genital Warts in Patients

    Recruiting

    3 1 1
    Investigated Diseases:
    • Skin papilloma
    Investigated Drugs:
    • Interferon Alfa
    • Interleukin-1
    • Interleukin-2
    Belgium

  • Study on the Effectiveness of 2LEBV and 2LXFS for Reducing Fatigue in Patients with Epstein-Barr Virus Infection

    Recruiting

    3 1 1
    Investigated Diseases:
    • Epstein-Barr virus infection
    • Epstein-Barr virus infection reactivation
    Investigated Drugs:
    • Deoxyribonucleic Acid
    • Interferon Alfa
    • Interferon Gamma
    Belgium

  • Study on Topiramate for Reactivating Hidden HIV in Patients with HIV on Antiretroviral Therapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Topiramate
    The Netherlands

  • Study on the Effectiveness of 2LHERP in Reducing Recurrent Cold Sores in Patients with Frequent Outbreaks

    Recruiting

    3 1 1
    Investigated Diseases:
    • Herpes simplex
    • Oral herpes
    Investigated Drugs:
    • Deoxyribonucleic Acid
    • Ribonucleic Acid
    • Specific Nucleic Acid Sna-Her1
    Belgium

  • Study on Rituximab for Preventing Epstein-Barr Virus Infection and Lymphoproliferative Disorders in EBV-Negative Kidney Transplant Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Epstein-Barr virus infection
    • Renal transplant
    Investigated Drugs:
    • Rituximab
    France

  • Study on Treating Resistant Viral Infections in Stem Cell Transplant Patients Using Allogeneic Multivirus-Specific T Cells

    Recruiting

    3 1
    Investigated Diseases:
    • Cytomegalovirus infection
    • Epstein-Barr virus infection
    • Adenovirus infection
    Investigated Drugs:
    • Allogeneic Cd4+ And Cd8+ T Lymphocytes Ex Vivo Incubated With Synthetic Peptides Of The Viral Antigens Of Cytomegalovirus, Adenovirus And Epstein-Barr Virus
    Belgium France Germany Italy The Netherlands
Previous Page
1 … 11 12 13 14 15 … 51
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!